Alexis Voke
Hollywood, FLNPI 1083252126
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,170, 4.5 times the $259 reported in 2022.
Across 114 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$340
- AbbVie$332
- Boehringer Ingelheim$246
- Lilly USA, LLC$238
- AstraZeneca$232
- GSK$180
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,860100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $340 |
| AbbVie | 15 | $332 |
| Boehringer Ingelheim | 2 | $246 |
| Lilly USA, LLC | 15 | $238 |
| AstraZeneca | 13 | $232 |
| GSK | 7 | $180 |
| Viiv Healthcare Company | 7 | $168 |
| Exact Sciences | 4 | $139 |
| Amgen | 7 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| Antares Pharma, Inc. | 5 | $113 |
| Esperion Therapeutics, Inc. | 5 | $105 |
| Novartis | 3 | $81 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| Pfizer | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Novo Nordisk | 2 | $37 |
| Lundbeck LLC | 1 | $31 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| Halozyme Inc | 1 | $25 |
| Tolmar, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.